Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2023 Filed May 19, 2023 21:37 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 971 | $1.98 | $1,922.58 |
DisclosureSEC source: 0001209191-23-031168 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,346 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:17 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 5,102 | $2.29 | $11,683.58 |
DisclosureSEC source: 0001209191-23-027340 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,408 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:00 UTC |
Tachibana AaronCFO and COO
|
SaleCommon Stock | 3,945 | $2.83 | $11,164.35 |
DisclosureSEC source: 0001209191-23-020375 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,283 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:57 UTC |
Chen RichardChief Medical Officer and EVP
|
SaleCommon Stock | 1,314 | $2.83 | $3,718.62 |
DisclosureSEC source: 0001209191-23-020372 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,317 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:08 UTC |
Hall Christopher MDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019860 · doc4.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:13 UTC |
Tachibana AaronCFO and COO
|
GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019871 · doc4.xml · derivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:19 UTC |
Moore Stephen MichaelGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019882 · doc4.xml · derivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:16 UTC |
Chen RichardChief Medical Officer and EVP
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019877 · doc4.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:12 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 767 | $2.20 | $1,687.40 |
DisclosureSEC source: 0001209191-23-006271 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,228 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:09 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 562 | $2.20 | $1,236.40 |
DisclosureSEC source: 0001209191-23-006269 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,631 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 22:07 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,843 | $1.92 | $7,378.56 |
DisclosureSEC source: 0001209191-22-062469 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,995 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 22:03 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,750 | $1.92 | $3,360.00 |
DisclosureSEC source: 0001209191-22-062465 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,193 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:28 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 7,177 | $2.50 | $17,942.50 |
DisclosureSEC source: 0001209191-22-061926 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,838 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:32 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,930 | $2.50 | $4,825.00 |
DisclosureSEC source: 0001209191-22-061932 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,510 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:23 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 7,177 | $2.50 | $17,942.50 |
DisclosureSEC source: 0001209191-22-061900 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,943 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 14, 2022 16:03 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001209191-22-061171 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,999 Underlying: Common Stock · 10,000 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| December 14, 2022 Filed Dec 14, 2022 16:03 UTC |
West John StephenDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,000 | $2.44 | $24,400.00 |
DisclosureSEC source: 0001209191-22-061171 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:54 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 4,360 | $2.60 | $11,336.00 |
DisclosureSEC source: 0001209191-22-060029 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,015 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:50 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 440 | $2.60 | $1,144.00 |
DisclosureSEC source: 0001209191-22-060025 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,120 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:43 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 1,294 | $2.71 | $3,506.74 |
DisclosureSEC source: 0001209191-22-057865 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,375 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 22:02 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,295 | $2.71 | $3,509.45 |
DisclosureSEC source: 0001209191-22-057904 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,560 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:48 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 2,045 | $2.71 | $5,541.95 |
DisclosureSEC source: 0001209191-22-057869 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,440 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 20:09 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,474 | $3.48 | $12,089.52 |
DisclosureSEC source: 0001209191-22-051008 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,669 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 20:13 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,581 | $3.48 | $5,501.88 |
DisclosureSEC source: 0001209191-22-051013 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,855 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 8, 2022 20:09 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 4,168 | $3.33 | $13,879.44 |
DisclosureSEC source: 0001209191-22-049145 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,143 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 8, 2022 20:18 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 420 | $3.33 | $1,398.60 |
DisclosureSEC source: 0001209191-22-049154 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,436 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:46 UTC |
West John StephenDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-046295 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2032-08-15 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:46 UTC |
West John StephenDirector · President and CEO
|
GrantCommon Stock | 230,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046295 · doc4.xml · nonDerivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,444 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 8 equal semi-annual installments with the first installment vesting on November 15, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:53 UTC |
Tachibana AaronChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 29,890 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-046309 · doc4.xml · derivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,890 Underlying: Common Stock · 29,890 shares Expires 2032-08-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:05 UTC |
Moore Stephen MichaelGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 28,700 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-046364 · doc4.xml · derivative · entry 2 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Underlying: Common Stock · 28,700 shares Expires 2032-08-15 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:05 UTC |
Moore Stephen MichaelGeneral Counsel
|
GrantCommon Stock | 18,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046364 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,485 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on November 15, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:00 UTC |
Chen RichardChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 29,890 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-046339 · doc4.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,890 Underlying: Common Stock · 29,890 shares Expires 2032-08-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| August 15, 2022 Filed Sep 8, 2022 01:59 UTC |
Moore Stephen MichaelGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 28,700 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-049091 · doc4.xml · derivative · entry 2 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Underlying: Common Stock · 28,700 shares Expires 2032-08-15 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| August 15, 2022 Filed Sep 8, 2022 01:59 UTC |
Moore Stephen MichaelGeneral Counsel
|
GrantCommon Stock | 18,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049091 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,485 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on November 15, 2022. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 21:47 UTC |
Shoff LonnieDirector
|
GrantStock Option (Right to Buy) · Derivative | 47,345 | $0.00 Strike: $4.07 | $0.00 |
DisclosureSEC source: 0001209191-22-044452 · doc4.xml · derivative · entry 2 Shoff Lonnie · CIK 0001471716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,345 Underlying: Common Stock · 47,345 shares Expires 2032-08-02 F2 · derivative.exercise_date: The shares subject to the option vest in 3 annual installments with the first installment vesting on August 2, 2023. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 21:47 UTC |
Shoff LonnieDirector
|
GrantCommon Stock | 30,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044452 · doc4.xml · nonDerivative · entry 1 Shoff Lonnie · CIK 0001471716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,940 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 3 annual installments with the first installment vesting on August 2, 2023. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 22:05 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 632 | $3.91 | $2,471.12 |
DisclosureSEC source: 0001209191-22-043731 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,311 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 22:12 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 632 | $3.91 | $2,471.12 |
DisclosureSEC source: 0001209191-22-043733 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,856 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:48 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 3,440 | $3.29 | $11,317.60 |
DisclosureSEC source: 0001209191-22-038443 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,943 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:52 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 1,565 | $3.29 | $5,148.85 |
DisclosureSEC source: 0001209191-22-038445 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,488 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:02 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 6,818 | $3.24 | $22,090.32 |
DisclosureSEC source: 0001209191-22-037952 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,383 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:11 UTC |
Moore Stephen MichaelGeneral Counsel
|
SaleCommon Stock | 1,832 | $3.24 | $5,935.68 |
DisclosureSEC source: 0001209191-22-037973 · doc4.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,885 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:08 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 6,818 | $3.24 | $22,090.32 |
DisclosureSEC source: 0001209191-22-037962 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,053 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:36 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 4,187 | $3.59 | $15,031.33 |
DisclosureSEC source: 0001209191-22-034616 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,201 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:30 UTC |
Chen RichardChief Medical Officer
|
SaleCommon Stock | 421 | $3.59 | $1,511.39 |
DisclosureSEC source: 0001209191-22-034599 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,871 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. F2 · balance_after: This reflects a reduction of 538 shares due to a scrivener's error on the reporting person's prior filings and does not indicate a purchase and/or sale of such shares. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:28 UTC |
BOWMAN A BLAINEDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030769 · doc4.xml · derivative · entry 2 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:28 UTC |
BOWMAN A BLAINEDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030769 · doc4.xml · nonDerivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,506 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:45 UTC |
MYERS WOODROW A JRDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030775 · doc4.xml · derivative · entry 2 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:45 UTC |
MYERS WOODROW A JRDirector
|
GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030775 · doc4.xml · nonDerivative · entry 1 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,116 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:38 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030771 · doc4.xml · derivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.